首页> 外国专利> Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative ,and use of these

Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative ,and use of these

机译:新型八氢噻吩并喹啉衍生物,包含该衍生物的药物组合物及其用途

摘要

The present invention provides compounds represented by the general formula (I): or pharmaceutical acceptable salts thereof, wherein R 1 is cyano or the like; R 2 and R 3 are hydrogen or the like; R 4 is C 1-6 alkyl or the like; R 5 is C 1-6 alkyl, halo-C 1-6 alkyl, cycloalkyl, cycloalkyl-C 1-6 alkyl, aralkyl or the like; R 6 and R 7 are each hydrogen, C 1-6 alkyl, halo-C 1-6 alkyl, cycloalkyl, C 1-6 alkoxy-C 1-6 alkyl, R 12 R 13 N-C 1-6 alkyl or the like, which exhibit potent dopamine D 2 receptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.
机译:本发明提供由通式(I)表示的化合物或其药学上可接受的盐,其中R 1是氰基等; R 2和R 3为氢等。 R 4为C 1-6烷基等。 R 5为C 1-6烷基,卤代-C 1-6烷基,环烷基,环烷基-C 1-6烷基,芳烷基等; R 6和R 7分别为氢,C 1-6烷基,卤代-C 1-6烷基,环烷基,C 1-6烷氧基-C 1-6烷基,R 12 R 13 NC 1-6烷基等,表现出有效的多巴胺D 2受体刺激活性。本发明还提供了包含所述化合物的药物组合物及其用途。

著录项

  • 公开/公告号IL228318D0

    专利类型

  • 公开/公告日2013-11-25

    原文格式PDF

  • 申请/专利权人 KISSEI PHARMACEUTICAL CO. LTD.;

    申请/专利号IL20130228318

  • 发明设计人

    申请日2013-09-09

  • 分类号C07D;

  • 国家 IL

  • 入库时间 2022-08-21 15:57:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号